ReviewInfectious diseases & immunity2026
Progress in research on mosquito-borne viruses: Understanding infection, transmission, and control.
Review in Infectious diseases & immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mosquito-borne viruses (MBVs) are a group of arboviruses belonging to diverse families and genera. Transmitted through mosquito bites, MBVs are a significant public health concern. These pathogens can cause a spectrum of mosquito-borne viral diseases (MBVDs) ranging from rashes, mild fever, and arthralgia to severe conditions, such as shock, encephalitis, microcephaly, hemorrhagic fever and even death. MBVDs are primarily endemic in tropical and subtropical regions, putting half of the global population at risk. Evolutionarily, these viruses are highly adapted to both mosquito and mammalian hosts, efficiently exploiting multiple characteristics of both hosts to facilitate the infection and transmission cycle. In this study, we review the current knowledge of the infection and transmission of major pathogenic MBVs, the underlying mechanisms thereof, and recent advances in preventing and controlling these viruses. We also highlight key challenges in MBV control, infection, and transmission while discussing prospective directions for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.